|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.70 TWD | -0.95% |
|
-0.32% | +6.45% |
| Market Cap | 11.2B 352M 308M 284M 266M 499M 33.16B 509M 3.41B 1.32B 16.39B 1.32B 1.29B 56.83B | P/E 2024 |
12.6x | P/E 2025 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.77B 306M 269M 248M 232M 435M 28.91B 444M 2.98B 1.15B 14.29B 1.15B 1.13B 49.54B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.29x |
| Free-Float |
43.02% | Yield 2024 |
4.52% | Yield 2025 | 3.4% |
| 1 day | -0.95% | ||
| 1 week | -0.32% | ||
| Current month | +1.79% | ||
| 1 month | +2.12% | ||
| 6 months | +5.38% | ||
| Current year | +6.45% |
| 1 week | 62 |  | 63.5 |
| 1 month | 61 | | 64.1 |
| Current year | 58.9 | | 66.6 |
| 1 year | 53.5 | | 66.6 |
| 3 years | 51.2 | | 79.4 |
| 5 years | 36.8 | | 79.6 |
| 10 years | 27.35 | | 79.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tzu Ting Fan
CEO | Chief Executive Officer | - | 2006-05-29 |
Reynold Hsu
DFI | Director of Finance/CFO | - | 2019-07-15 |
Wei Jen Chen
PRN | Corporate Officer/Principal | - | 2001-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Chin Tsai Fan
CHM | Chairman | - | 1967-06-29 |
Yuan Te Li
BRD | Director/Board Member | - | 2012-06-05 |
Tsui Wen Yeh
BRD | Director/Board Member | - | 2002-05-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | -0.32% | +9.04% | -9.13% | 352M | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | |
| +0.99% | +4.85% | +28.17% | +22.04% | 332B | |
| +1.82% | +8.19% | +40.04% | +27.45% | 293B | |
| +0.22% | +6.75% | +31.30% | +42.64% | 286B | |
| +0.73% | +8.53% | -27.33% | -40.29% | 215B | |
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | |
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | |
| Average | +2.29% | +7.64% | +28.79% | +48.33% | 361.64B | |
| Weighted average by Cap. | +3.85% | +9.65% | +41.75% | +81.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.79B 213M 187M 172M 161M 302M 20.09B 308M 2.07B 801M 9.93B 800M 782M 34.43B | 7.02B 220M 193M 178M 167M 313M 20.78B 319M 2.14B 828M 10.27B 827M 809M 35.62B |
| Net income | 881M 27.62M 24.22M 22.33M 20.9M 39.19M 2.61B 40.01M 268M 104M 1.29B 104M 101M 4.47B | 928M 29.1M 25.52M 23.52M 22.02M 41.29M 2.75B 42.15M 283M 109M 1.36B 109M 107M 4.7B |
| Net Debt | -1.24B -39.01M -34.21M -31.53M -29.52M -55.35M -3.68B -56.5M -379M -147M -1.82B -146M -143M -6.31B | -1.44B -45.06M -39.51M -36.42M -34.09M -63.93M -4.25B -65.26M -438M -169M -2.1B -169M -165M -7.28B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | NT$62.70 | -0.95% | 239,989 |
| 26-06-25 | NT$63.30 | +0.32% | 118,580 |
| 26-06-24 | NT$63.10 | +0.48% | 222,620 |
| 26-06-23 | NT$62.80 | +0.32% | 297,619 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1720 Stock
Select your edition
All financial news and data tailored to specific country editions
